サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1265633

次世代シーケンサー（NGS）サンプル調製の世界市場

Next Generation Sequencing (NGS) Sample Preparation
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 88 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
次世代シーケンサー（NGS）サンプル調製の世界市場
出版日: 2023年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 88 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

次世代シーケンサー（NGS）サンプル調製についての世界市場は2030年までに94億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に27億米ドルと推定される次世代シーケンサー（NGS）サンプル調製についての世界市場は、2030年までに94億米ドルの改定規模に達し、2022年から2030年にかけてCAGR17％で成長すると予測されます。本レポートで分析したセグメントの一つである試薬・消耗品は、CAGR19%を記録し、分析期間終了時には62億米ドルに達すると予測されます。パンデミック後の回復を考慮し、ワークステーション分野の成長率は、今後8年間のCAGRを13.8%に修正しました。

米国市場は7億8,830万米ドル、中国はCAGR15.9%で成長すると予測

米国の次世代シーケンサー（NGS）サンプル調製について市場は、2022年に7億8,830万米ドルと推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが15.9％となり、2030年には16億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ14.6％と13.7％の成長が予測されています。欧州では、ドイツがCAGR10.9%で成長すると予測されています。

調査対象企業の例

  • Agilent Technologies
  • Beckman Coulter（A Subsidiary of Danaher）
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP22379

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach $9.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$2.7 Billion in the year 2022, is projected to reach a revised size of US$9.4 Billion by 2030, growing at aCAGR of 17% over the period 2022-2030. Reagents & Consumables, one of the segments analyzed in the report, is projected to record 19% CAGR and reach US$6.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Workstations segment is readjusted to a revised 13.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $788.3 Million, While China is Forecast to Grow at 15.9% CAGR

The Next Generation Sequencing (NGS) Sample Preparation market in the U.S. is estimated at US$788.3 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 15.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.6% and 13.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.

Select Competitors (Total 32 Featured) -

  • Agilent Technologies
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • Berry Genomics
  • BGI
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Macrogen
  • New England Biolabs, Inc.
  • Novo Gene
  • Nugen Technologies, Inc.
  • Oxford Gene Technology
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V
  • Raindance Technologies, Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher
  • WuXi AppTec

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Next Generation Sequencing (NGS) Sample Preparation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Semi-Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 2: World 10-Year Perspective for Semi-Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for NGS Library Preparation Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 4: World 10-Year Perspective for NGS Library Preparation Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Automated Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 6: World 10-Year Perspective for Automated Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clonal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 8: World 10-Year Perspective for Clonal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 10: World 10-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 12: World 10-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Consumer Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 14: World 10-Year Perspective for Consumer Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Metagenomics, Epidemiology & Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 16: World 10-Year Perspective for Metagenomics, Epidemiology & Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Agrigenomics & Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 18: World 10-Year Perspective for Agrigenomics & Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for HLA Typing / Immune System Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 20: World 10-Year Perspective for HLA Typing / Immune System Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 22: World 10-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 24: World 10-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 26: World 10-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Pharma & Biotech Entities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 28: World 10-Year Perspective for Pharma & Biotech Entities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 30: World 10-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 31: World Next Generation Sequencing (NGS) Sample Preparation Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 33: World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 35: World 10-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Workstations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 37: World 10-Year Perspective for Workstations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2021 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 39: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 41: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 43: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 45: USA 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • CANADA
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 47: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 49: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 51: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 53: Canada 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • JAPAN
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2021 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 55: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 57: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 59: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 61: Japan 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • CHINA
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2021 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 63: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 65: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 67: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 69: China 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • EUROPE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2021 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 71: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 73: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 75: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2030 and % CAGR
    • TABLE 77: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 79: Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • FRANCE
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2021 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 81: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 82: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 83: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 85: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 87: France 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • GERMANY
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2021 (E)
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 89: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 90: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 91: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 93: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 95: Germany 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • ITALY
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 97: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 99: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 100: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 101: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 103: Italy 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • UNITED KINGDOM
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2021 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 105: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 106: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 107: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 108: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 109: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 111: UK 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • REST OF EUROPE
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 114: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 115: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 117: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 118: Rest of Europe Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 119: Rest of Europe 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • ASIA-PACIFIC
    • Next Generation Sequencing (NGS) Sample Preparation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2021 (E)
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 124: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 125: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 126: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 127: Asia-Pacific 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030
  • REST OF WORLD
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 129: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Workflow - Percentage Breakdown of Value Sales for Semi-Automated Library Preparation, NGS Library Preparation Kits, Automated Library Preparation and Clonal Amplification for the Years 2021 & 2030
    • TABLE 130: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Application - Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 131: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Application - Percentage Breakdown of Value Sales for Agrigenomics & Forensics, HLA Typing / Immune System Monitoring, Other Applications, Oncology, Consumer Genomics and Metagenomics, Epidemiology & Drug Development for the Years 2021 & 2030
    • TABLE 132: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 133: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by End-Use - Percentage Breakdown of Value Sales for Academic Research, Clinical Research, Hospitals & Clinics, Pharma & Biotech Entities and Other End-Uses for the Years 2021 & 2030
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) Sample Preparation by Product - Reagents & Consumables and Workstations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2030 and % CAGR
    • TABLE 135: Rest of World 10-Year Perspective for Next Generation Sequencing (NGS) Sample Preparation by Product - Percentage Breakdown of Value Sales for Reagents & Consumables and Workstations for the Years 2021 & 2030

IV. COMPETITION